台股 » 個股 » 中化生 » 籌碼相關 » 券商分點績效

中化生

(1762)
可現股當沖
  • 股價
    44.90
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    149
  • 產業
    上市 生技醫療類股▼0.17%
  • 252人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
中化生 (1762)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/19 ~ 2024/04/26     後一日»

券商獲利排行 - 2024/04/19 ~ 2024/04/26

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  2.53%38.330.47.98342644.443.945.144.9
  0.27%19.522.8-3.3-877616344.844.644.944.9
  1.74%18.67.810.81724744.544.345.444.9
  0.82%16.3016.3-4404445.3045.344.9
  0.41%12.38.24.131673544.944.84544.9
  2.13%9.41.4881024443.944.644.9
  2.21%7.970.9-35844.743.845.244.9
  1.24%7.707.71414044.344.3044.9
  0.35%6.86.70.2-7374444.844.744.944.9
  0.29%6.30.45.9-4264845454544.9
  1.04%6061313044.444.4044.9
  2.43%5.305.355043.843.8044.9
  0.66%53.81.23171444.644.544.844.9
  2.15%4.81.43.445144.344.145.444.9
  2.06%4.64.40.2-14544.64445.144.9
  2.05%4.504.55504444044.9
  0.90%4.404.41111044.544.5044.9
  0.90%4041010044.544.5044.9
  0.86%3.93.30.6-18104544.845.244.9
  1.65%3.72.51.2-22544.94445.344.9
  2.75%3.603.623043.743.745.444.9
  1.58%3.503.555044.244.2044.9
  0.51%3.403.41515044.744.7044.9
  1.86%3.32.21.124244.744.445.544.9
  2.47%3.303.333043.843.8044.9
  0.24%3.2-1.44.616301444.644.644.544.9
  0.55%3.21.91.3-841344.944.64544.9
  2.37%3.103.133043.943.9044.9
  1.37%3.11.21.935244.544.344.944.9
  2.29%31223144.143.944.944.9
  1.61%2.902.944044.244.244.644.9
  1.28%2.91.51.435244.744.445.244.9
  2.03%2.71.7113244.243.944.744.9
  0.57%2.62.40.1-271044.844.64544.9
  1.80%2.41.80.613244.644.345.244.9
  0.88%2.41.11.226444.444.344.644.9
  0.86%2.311.346244.744.645.144.9
  2.59%2.32.3002244.443.84544.9
  1.25%2.21.80.4-22444.844.245.144.9
  2.51%2.202.222043.843.8044.9
  0.58%2.10.31.738444.544.544.644.9
  1.55%2.102.133044.244.2044.9
  1.53%20233044.244.2044.9
  2.28%20222043.943.9044.9
  2.28%20222043.943.9044.9
  2.26%22002244.343.844.844.9
  1.47%22003344.143.844.544.9
  2.07%1.81.8002244.644.245.144.9
  1.35%1.801.833044.344.3044.9
  0.67%1.81.20.6-51644.943.94544.9

券商虧損排行 - 2024/04/19 ~ 2024/04/26

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.29%-35.7-8.4-27.3-5396244.545.344.444.9
  -3.12%-22.3-22.300161644.845.544.144.9
  -2.18%-19.6-19.600202044.945.444.444.9
  -2.08%-15.6-0.9-14.6-161174444.94444.9
  -0.48%-15.1-16.51.322714944.744.844.544.9
  -1.09%-13.2-6.5-6.7212764545.244.144.9
  -0.42%-12.9-2.3-10.6636854545.144.644.9
  -0.84%-12.30-12.3-3203344.544.644.544.9
  -2.51%-12.10-12.1-1001143.844.243.844.9
  -0.43%-11.7-0.2-11.5-5646144.744.744.744.9
  -2.63%-11.50-11.5-901043.84543.844.9
  -2.86%-11.30-11.3-90943.7043.744.9
  -2.42%-10.60-10.6-1001043.8043.844.9
  -2.04%-10-1001111044.544.94444.9
  -2.18%-9.60-9.6-901043.944.543.944.9
  -0.30%-9.6-1.8-7.8577114454544.944.9
  -2.05%-7.20-7.2-8084404444.9
  -2.45%-6.50-6.5-60643.8043.844.9
  -2.28%-60-6-50643.944.543.944.9
  -2.39%-5.30-5.3-50543.9043.944.9
  -0.17%-5-2.8-2.1-24416544.844.944.844.9
  -1.33%-4.70.2-4.9-71844.24444.244.9
  -0.92%-4.50.7-5.2-921144.34444.344.9
  -2.51%-4.40-4.4-40443.8043.844.9
  -0.18%-40.7-4.749501454545.744.9
  -2.12%-2.80-2.8-3034445.24444.9
  -0.79%-2.80-2.8-80844.6044.644.9
  -0.95%-2.50.5-3-42644.143.944.244.9
  -0.99%-2.20-2.255045.445.4044.9
  -0.95%-2.10-2.155045.345.3044.9
  -0.59%-2.10-2.1-80844.6044.644.9
  -2.36%-2.1-2.1002244.545.14444.9
  -0.50%-20-289045.145.145.344.9
  -0.45%-20-2-901044.745.344.744.9
  -2.28%-20-2-20243.9043.944.9
  -0.88%-20-255045.345.3044.9
  -1.39%-1.90-1.9-30344.3044.344.9
  -2.05%-1.80-1.8-2024404444.9
  -0.64%-1.7-0.6-1.15614545.144.644.9
  -1.93%-1.7-1.7002244.645.144.244.9
  -0.47%-1.70-1.7-80844.745.144.744.9
  -0.59%-1.60-1.666045.245.2044.9
  -0.29%-1.60-1.6-1201244.8044.844.9
  -1.10%-1.50-1.533045.445.4044.9
  -0.80%-1.4-0.6-0.824245.245.34544.9
  -0.66%-1.20-1.244045.245.2044.9
  -0.49%-1.10.1-1.2-32544.544.544.544.9
  -2.51%-1.10-1.1-10143.8043.844.9
  -1.22%-1.1-0.9-0.2-1124545.644.744.9
  -2.39%-1.10-1.100143.945.443.944.9
中化生魚油原料藥產能倍增最快年底過美認證 明年營收再登高Anue鉅亨-2022/11/14
年度傑出生技產業獎 中化生、藥華藥入列Anue鉅亨-2022/07/22
〈中國限電〉中印限電危機原料藥再度供給失衡 中化生、台耀迎轉單潮Anue鉅亨-2021/10/07
中化生 相關文章